Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001756460 | SCV001985238 | uncertain significance | not provided | 2020-08-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001756460 | SCV002196150 | uncertain significance | not provided | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 267 of the SP7 protein (p.Arg267Cys). This variant is present in population databases (rs201666834, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with SP7-related conditions. ClinVar contains an entry for this variant (Variation ID: 1302961). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome Diagnostics Laboratory, |
RCV002276880 | SCV002565036 | uncertain significance | Osteogenesis imperfecta | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040064 | SCV003701668 | uncertain significance | not specified | 2022-08-17 | criteria provided, single submitter | clinical testing | The c.799C>T (p.R267C) alteration is located in exon 3 (coding exon 2) of the SP7 gene. This alteration results from a C to T substitution at nucleotide position 799, causing the arginine (R) at amino acid position 267 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV001756460 | SCV005408337 | uncertain significance | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | BP4, PM2 |